Combined treatment of endometriosis in infertile patients with gonadotropin-releasing hormone agonist or dienogest

Condition tags

Citation neighborhood (2-hop)

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. Outer rings show 2-hop neighbours — papers reached through the immediate citers/citees. [ collapse to 1-hop ]

References (14)

• A dose-ranging study to determine the efficacy and safety of 1, 2, and 4mg of dienogest daily for endometriosis via openalex
• An evidence-based evaluation of endometriosis-associated infertility via openalex
• Decorin induced by progesterone plays a crucial role in suppressing endometriosis via openalex
• Dienogest compared with gonadotropin-releasing hormone agonist after conservative surgery for endometriosis via openalex
• Dienogest in the treatment of endometriosis-associated pelvic pain: a 12-week, randomized, double-blind, placebo-controlled study via openalex
• Endometriosis: alternative methods of medical treatment via openalex
• Management of infertility in women with endometriosis via openalex
• Medical management of endometriosis and infertility via openalex
• Medical treatments for endometriosis-associated pelvic pain via openalex
• [MINIMAL AND MILD ENDOMETRIOSIS: WHICH IMPACT ON FERTILITY?] via openalex
• Novel Medical Treatment Modalities of Endometriosis via openalex
• Reduced pelvic pain in women with endometriosis: efficacy of long-term dienogest treatment via openalex
• Urinary incontinence and bladder endometriosis: conservative management via openalex
• Use of dienogest over 53 weeks for the treatment of endometriosis via openalex

Source provenance

openalex

last seen: 2026-06-10T17:14:06.276822+00:00